The veterinary pharmaceutical sector is continuously evolving, driven by the need for more effective, safer, and versatile treatments for animal health. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of this evolution, actively developing innovative pharmaceutical ingredients that push the boundaries of what's possible. Our work on novel molecular salts of Enrofloxacin Hydrochloride is a prime example of this forward-thinking approach.

Enrofloxacin Hydrochloride, a widely utilized fluoroquinolone antibiotic, plays a critical role in managing bacterial diseases in animals. However, its therapeutic utility has been somewhat limited by its poor solubility in water. This inherent property can affect how the drug is absorbed and utilized by the animal, potentially impacting treatment success. NINGBO INNO PHARMCHEM CO.,LTD. has addressed this challenge through advanced chemical research, focusing on crystal engineering to create new salts of Enrofloxacin Hydrochloride.

By forming crystalline complexes with specific co-formers, such as isomeric pyridine-2,n-dicarboxylic acids, we have developed new forms of Enrofloxacin Hydrochloride that exhibit significantly enhanced water solubility. In some cases, the solubility has increased by over 100-fold, a remarkable improvement that directly translates to better bioavailability. This means the active ingredient is more readily available to combat infections, leading to potentially more effective and rapid treatment outcomes.

Moreover, these advanced Enrofloxacin Hydrochloride salts retain the broad-spectrum antibacterial activity that makes the original compound so valuable. They are effective against a wide range of Gram-positive and Gram-negative bacteria, ensuring their utility across various species and infection types. Importantly, the research also indicates a favorable safety profile, with negligible hemolytic activity observed at therapeutic concentrations. This comprehensive enhancement of solubility, efficacy, and safety positions these new salts as key components for future veterinary pharmaceutical products.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying the market with API intermediates that offer tangible benefits. These Enrofloxacin Hydrochloride salts represent a significant advancement, enabling the development of next-generation veterinary medicines with broader applications and improved treatment efficacy. We are confident that these innovations will contribute substantially to the well-being of animals worldwide.